We know that interest among patients for GLP-1s is high, especially in people trying to lose weight, but injection delivery is one of the key barriers
The most cited mechanistic finding is from a 2017 study published in the Journal of Molecular Medicine , in which Hsieh and colleagues reported that BPC-157 promotes angiogenesis in CAM assay and tube formation assay and accelerated blood-flow recovery in a rat hindlimb ischemia model, with the effect attributed to activation of the VEGFR2AkteNOS signaling pathway [1]
In 2019, oral semaglutide received approval as the first oral GLP-1 receptor agonist [22]
Common mechanisms of vision decline Oxidative stress: Retina, particularly photoreceptors, faces extreme oxidative burden from light exposure and high metabolic rate
doi:10.1016/S0140-6736(23)01233-3 95
Peters and colleagues in CEN Case Reports 2020 documented the first published case of renal infarction temporally associated with MT-II use: a 45-year-old previously healthy male presented with right-sided renal infarction affecting approximately half of the kidney, with persistent hypertension and reduced glomerular filtration rate at follow-up [10]